Assembly Biosciences
(STG) V7B1
Assembly Biosciences Financials at a Glance
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$61.23
Net Income (TTM)
-$5.65
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
N/A
V7B1 News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Assembly Biosciences
V7B1 Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
N/A
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Payout Ratio
N/A
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Assembly Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.02
+0.8%
Gross Profit
$7.00
+0.8%
Gross Margin
99.68%
+1.0%
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$5.15
N/A
Employees
73
N/A
Net Income
-$7.76
+0.9%
EBITDA
-$9.70
+1.0%
Quarterly Fundamentals
Total Cash
$29.17
+19.2%
Total Debt
$2.16
+0.8%
Accounts Receivable
$0.39
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.65
+0.7%
Short Term Debt
$0.51
+1.0%
Return on Assets
-3.82%
+0.1%
Return on Invested Capital
-88.97%
+0.9%
Free Cash Flow
-$18.90
+0.8%
Operating Cash Flow
-$18.89
+0.8%